Followed by G194R and N211K mutations, whose clinical phenotype is different from D214N/Y, mainly gelsolin-related renal amyloidosis (Sethi et al., 2013; Efebera et al., 2014). The gene discussed is GSN; the disease is Renal amyloidosis.